Rod shares his journey from stock picking to building a concentrated portfolio focused on high-probability investments in healthcare. He highlights the evolution of his firm, emphasizing the importance of identifying and nurturing underappreciated academic projects into impactful companies, like Rocket Pharma, which stands out as a significant achievement in his career.
